Paeditric medications in 2024, availability and perspectives
Anne-Laure Clairet, PhD
Hospital pharmacist in the University of Besançon:
Clinical pharmacist: in the oncology and paeditrics departments, ensuring patient care pathways, Drug management in clinical trials, Outpatiend drug dispensing
Associate Professor in the UFR “Sciences de la Santé de Besançon” University of Franche-Comté
Clinical pharmacy course of the Faculty of Pharmacy and for pharmacy technicians, Simulation-based teaching
PhD thesis about Managing medication risks in specific contexts: typology and epidemiology
Carlos Javier Parramon Teixido, Hospital pharmacist – Val d’Hebron Barcelona Hospital Campus
I am a Hospital Pharmacist and I work at the Pharmacy Service of Vall d’Hebron Campus Hospital. I manage medication and provide pharmaceutical care focused on the safe use of medications, preparing medications for individualized treatments for both inpatients and outpatients. I belong to the Basic, Translational, and Clinical Pharmacy research group at Vall Hebron Research Institute, which primarily focuses on personalized medicine. I am involved in pediatrics, particularly in Neonatology, and in preparing both sterile and non-sterile medications for pediatric patients. Regarding medication preparation, I am pursuing a Ph.D. at the University of Santiago de Compostela on 3D printing of medications for pediatrics in the hospital setting.
Nicolas Rollet, Ph.D – Head of Formulation & Analytical expert, Adexpharma
I have 15 years of experience in R&D, and I presently has a position of Head of Formulation and Analytical Expert at AdhexPharma. By training, I have got my PhD within CNRS in the Institut de Chimie Moléculaire from University of Burgundy (ICMUB). In the first 10 years, my activities were particularly focused on the development of analytical methods for specific galenic formulation (topical forms such as transdermal patches, thin films, semi-solid forms, …), cosmetics and medical devices (implants, …), along with the management of scientific teams and laboratories. In the past 5 years, I have been started other scientific activities, especially focused on formulation and conception of new drug product design and delivery systems such as transdermal patches and thin films. I have also been implemented the R&D activities during my several leadership positions, and I have been committed to the development of academia-industry relationships. I get co-inventor of patents about new identification technology and innovative manufacturing technologies. Plus, I am managing a PhD thesis in collaboration with the Department of Pharmacy at the University of Burgundy.
Prof. Joseph Standing – Great Ormond Street Institute of Child Health, University College London
Prof. Standing is an academic and hospital pharmacist who holds a PhD in clinical pharmacology, and MSc in Statistics. Prior to becoming a professor he held two UK Medical Research Council academic fellowships (Methodology 2011-2015, Clinician Scientist 2015-2020) which led to the development of a paediatric pharmacometrics research group at the UCL Great Ormond Street Institute of Child Health. The main research interests of the group are in undertaking clinical and pre-clinical pharmacokinetic-pharmacodynamic (PKPD) with the aim to improve the evidence base of medicines for children. Therapeutic areas include infectious diseases, oncology, critical care and neurology. The group is funded from research council and European agencies, charities/non-profit, and pharmaceutical industry collaborations. In addition Prof Standing Leads a MSc module and short-course entitled “Pharmacometrics”, where students gain theoretical and practical computational knowledge on population PKPD.
Catherine TULEU, Docteur en Pharmacie, PhD, is Professor in Paediatric Pharmaceutics at UCL School of Pharmacy, UK. (https://orcid.org/0000-0001-8384-357X ; H-index 31)
Her research, inherently translational, ranges from formulation, methodology development to clinical implementation, integrating the following themes: children centric excipient research; repurposing by reformulating for better medicines for children; development of innovative age appropriate dosage forms (especially for under 5s); administration issues and devices and sensory pharmaceuticsTM (dosage form acceptability and in vitro/in vivo taste assessment).
https://www.ucl.ac.uk/pharmacy/people/professor-catherine-tuleu
Her spin out company senCeuTics Ltd. specializes in pharmaceutical sensory evaluation and offers a full spectrum of preclinical, clinical and paediatric formulation services under one roof.
https://senceutics.com/
She is the founder and chairperson of the European Paediatric Formulation Initiative (EuPFI), a consortium working in a pre-competitive way on paediatric drug formulations.
http://www.eupfi.org/
https://www.linkedin.com/in/catherine-tuleu-9b842214/